Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
586.49
+10.14 (1.76%)
At close: Nov 11, 2025, 4:00 PM EST
587.77
+1.28 (0.22%)
After-hours: Nov 11, 2025, 7:58 PM EST
Thermo Fisher Revenue
Thermo Fisher had revenue of $11.12B in the quarter ending September 27, 2025, with 4.94% growth. This brings the company's revenue in the last twelve months to $43.74B, up 3.22% year-over-year. In the year 2024, Thermo Fisher had annual revenue of $42.88B with 0.05% growth.
Revenue (ttm)
$43.74B
Revenue Growth
+3.22%
P/S Ratio
5.08
Revenue / Employee
$349,888
Employees
125,000
Market Cap
220.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 42.88B | 22.00M | 0.05% |
| Dec 31, 2023 | 42.86B | -2.06B | -4.58% |
| Dec 31, 2022 | 44.92B | 5.70B | 14.55% |
| Dec 31, 2021 | 39.21B | 6.99B | 21.71% |
| Dec 31, 2020 | 32.22B | 6.68B | 26.14% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
TMO News
- 5 days ago - Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases - Business Wire
- 5 days ago - Thermo Fisher Scientific Declares Quarterly Dividend - Business Wire
- 13 days ago - Thermo Fisher To Acquire Clario Holdings For $8.875 Billion, Expands Digital Pharma Capabilities - Benzinga
- 13 days ago - Thermo Fisher to buy clinical services provider Clario for up to $9.4 billion - Reuters
- 13 days ago - Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion - WSJ
- 13 days ago - Thermo Fisher to buy clinical services provider Clario - Reuters
- 13 days ago - Thermo Fisher Scientific to Acquire Clario Holdings, Inc., Enabling Pharma and Biotech Customers to Accelerate Innovation with Deeper Clinical Insights - Business Wire
- 14 days ago - 14-year-old Combines Origami and Physics to Engineer Foldable Structures for Disaster Relief Shelters; Wins $25,000 Top Award at Thermo Fisher Scientific Junior Innovators Challenge - GlobeNewsWire